RÉSUMÉ
ABSTRACT: This study evaluated perampanel pharmacokinetics and cytochrome P450 3A4 (CYP3A4) activity, assessed using the level of 4ß-hydroxycholesterol (4ß-OHC) as an endogenous biomarker of CYP3A4, before, during, and after pregnancy in a woman with epilepsy and compared these measurements with those from a control group of nonpregnant women with epilepsy. A 21-year-old pregnant woman was being treated with perampanel (serum concentration: 1120 ng/mL), lacosamide, and lamotrigine. After the first trimester, the lamotrigine concentration decreased markedly; however, the perampanel concentration remained almost unchanged (range, 1130-1320 ng/mL). Similarly, serum 4ß-OHC levels did not change during pregnancy (before pregnancy, 78.2 ng/mL; during pregnancy, 62.2-83.2 ng/mL). To compare these measurements with those in nonpregnant women, we enrolled 27 nonpregnant women with epilepsy (age range, 16-40 years). In the control patients, we found a strong negative correlation between the concentration-to-dose ratio of perampanel and the 4ß-OHC level ( r = -0.78, P < 0.001). As there was no significant change in CYP3A4 activity, we concluded that the serum perampanel concentration did not change significantly before, during, or after pregnancy. More patients need to be studied to confirm these early results.
Sujet(s)
Anticonvulsivants , Cytochrome P-450 CYP3A , Épilepsie , Nitriles , Pyridones , Humains , Femelle , Pyridones/pharmacocinétique , Pyridones/sang , Pyridones/usage thérapeutique , Grossesse , Cytochrome P-450 CYP3A/métabolisme , Anticonvulsivants/pharmacocinétique , Anticonvulsivants/usage thérapeutique , Anticonvulsivants/sang , Nitriles/pharmacocinétique , Adulte , Jeune adulte , Épilepsie/traitement médicamenteux , Adolescent , Lamotrigine/pharmacocinétique , Lamotrigine/usage thérapeutique , Lamotrigine/sang , Complications de la grossesse/traitement médicamenteux , Lacosamide/pharmacocinétique , Lacosamide/usage thérapeutique , HydroxycholestérolsRÉSUMÉ
OBJECTIVE: We investigated neuropsychological outcome in patients with pharmacoresistant pediatric-onset epilepsy caused by focal cortical dysplasia (FCD), who underwent frontal lobe resection during adolescence and young adulthood. METHODS: Twenty-seven patients were studied, comprising 15 patients who underwent language-dominant side resection (LDR) and 12 patients who had languagenondominant side resection (n-LDR). We evaluated intelligence (language function, arithmetic ability, working memory, processing speed, visuo-spatial reasoning), executive function, and memory in these patients before and two years after resection surgery. We analyzed the relationship between neuropsychological outcome and resected regions (side of language dominance and location). RESULTS: Although 75% of the patients showed improvement or no change in individual neuropsychological tests after surgical intervention, 25% showed decline. The cognitive tests that showed improvement or decline varied between LDR and n-LDR. In patients who had LDR, decline was observed in Vocabulary and Phonemic Fluency (both 5/15 patients), especially after resection of ventrolateral frontal cortex, and improvement was observed in WCST-Category (7/14 patients), Block Design (6/15 patients), Digit Symbol (4/15 patients), and Delayed Recall (3/9 patients). In patients who underwent n-LDR, improvement was observed in Vocabulary (3/12 patients), but decline was observed in Block Design (2/9 patients), and WCST-Category (2/9 patients) after resection of dorsolateral frontal cortex; and Arithmetic (3/10 patients) declined after resection of dorsolateral frontal cortex or ventrolateral frontal cortex. General Memory (3/8 patients), Visual Memory (3/8 patients), Delayed Recall (3/8 patients), Verbal Memory (2/9 patients), and Digit Symbol (3/12 patients) also declined after n-LDR. CONCLUSION: Postoperative changes in cognitive function varied depending on the location and side of the resection. For precise presurgical prediction of neuropsychological outcome after surgery, further prospective studies are needed to accumulate data of cognitive changes in relation to the resection site.
Sujet(s)
Épilepsie temporale , Épilepsie , Dysplasie corticale focale , Enfant , Humains , Adolescent , Jeune adulte , Adulte , Résultat thérapeutique , Épilepsie/étiologie , Épilepsie/chirurgie , Épilepsie/psychologie , Lobe frontal/imagerie diagnostique , Lobe frontal/chirurgie , Mémoire à court terme , Tests neuropsychologiques , Épilepsie temporale/chirurgie , Études rétrospectivesRÉSUMÉ
Magnetoencephalography (MEG) and magnetic source imaging (MSI) are becoming increasingly important modalities in the functional neuroimaging of children. MEG is the magnetic equivalent of electroencephalography (EEG) and is thus capable of noninvasively characterizing neuronal activity on a millisecond time scale. MSI combines this functional information provided by MEG with the high anatomic detail of conventional magnetic resonance imagings. Considerable effort is placed on analyzing the configuration and number of spike waves by MEG that relate to a primary epileptiform discharge. Such MEG spike clusters are corroborated now by intraoperative invasive subdural grid monitoring that show good correlation in the majority of cases. Another important role of MEG relates to the mapping of critical regions of brain function using known paradigms for speech, motor, sensory, visual, and auditory brain cortex. In this review, I would introduce the background of MEG, data acquisition and analysis, and clinical application of MEG in children with epilepsy.